ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Pharmaceutical Patents in Developing Countries Policy Options

Countries: Policy Options Kumariah Balasubramaniam The Paris Convention for the protection of industrial property originally signed in 1883 has since been revised six times. Each revision has extended the exclusive monopoly powers of the patent holders and weakened the bargaining powers of developing countries which have to purchase technology from TNCs who own the majority of the patents. Most national legislations have incorporated the major provisionsof whether the countries are members of the Paris Union or not. A criticaland international patent systems reveals that these have had an adverse effecttechnological development of the pharmaceutical sector in the Asian and in the Paris Convention regardless examination of the existing national on the economic, commercial and other developing countries.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top